Podcasts about our phase

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is excited to announce the release of the latest episode of The Bell2Bell Podcast, recorded live from the Alzheimer's Association International Conference® 2024 (AAIC®) in Philadelphia. This release is part of IBN's ongoing efforts to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell's latest podcast features Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Annovis Bio's recent Phase 2/3 Alzheimer's study of its lead drug candidate, buntanetap. During the interview, she provides insights into how the scientific community is reacting to the promising data and what it could mean for the future of neurodegenerative disease treatment. Additionally, Dr. Maccecchini discusses Annovis Bio's strategic plans moving forward, including potential regulatory milestones and upcoming clinical trials that aim to further validate the efficacy and safety of buntanetap in treating both Parkinson's and Alzheimer's diseases. “Our Phase 2/3 data indicates that buntanetap has the potential to significantly improve the quality of life for early Alzheimer's patients,” said Dr. Maccecchini during the interview. “Being able to share these findings live from AAIC, one of the most prestigious events in Alzheimer's research, underscores the importance of our work and the promise it holds for patients.” Join IBN's Stuart Smith and Dr. Maria Maccecchini to learn more about Annovis Bio's recent achievements, the next steps for buntanetap, and the company's future goals. To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com. The latest installment of The Bell2Bell Podcast continues to reinforce IBN's commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies. To learn more about IBN's achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is excited to announce the release of the latest episode of The Bell2Bell Podcast, recorded live from the Alzheimer's Association International Conference® 2024 (AAIC®) in Philadelphia. This release is part of IBN's ongoing efforts to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell's latest podcast features Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Annovis Bio's recent Phase 2/3 Alzheimer's study of its lead drug candidate, buntanetap. During the interview, she provides insights into how the scientific community is reacting to the promising data and what it could mean for the future of neurodegenerative disease treatment. Additionally, Dr. Maccecchini discusses Annovis Bio's strategic plans moving forward, including potential regulatory milestones and upcoming clinical trials that aim to further validate the efficacy and safety of buntanetap in treating both Parkinson's and Alzheimer's diseases. “Our Phase 2/3 data indicates that buntanetap has the potential to significantly improve the quality of life for early Alzheimer's patients,” said Dr. Maccecchini during the interview. “Being able to share these findings live from AAIC, one of the most prestigious events in Alzheimer's research, underscores the importance of our work and the promise it holds for patients.” Join IBN's Stuart Smith and Dr. Maria Maccecchini to learn more about Annovis Bio's recent achievements, the next steps for buntanetap, and the company's future goals. To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com. The latest installment of The Bell2Bell Podcast continues to reinforce IBN's commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies. To learn more about IBN's achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Our Phase 4 MCU rewatch concludes today with Doctor Strange in the Multiverse of Madness. We discuss why we feel this movie didn't fully get a fair shake and how it actually ages fairly well on a rewatch. Next week kicks off one month of Deadpool coverage including a watch through of both Deadpool 1 and Deadpool 2. You won't want to miss it! Learn more about your ad choices. Visit megaphone.fm/adchoices

CinemaSpace Podcast #221 - Ant-Man and the Wasp: Quantumania, Join Aaron, Johnny, Paul and Cesar as they talk about this movie that is currently in theaters at the time of this recording and then go into our theories for phase 5 . Please let us know in the comments below of what you think of this film or any of the topics we talked about, we would really like to hear what you have to say.   00:01:54 - spoiler free thoughts 00:14:28 - Spoiler Section 01:00:32 - Our Phase 5 theories 01:24:46 - next week's movie   You can follow us on Instagram @cinemaspacepodcast You can like us on Facebook.com/cinemaspacepodcast You can follow us on Twitter @cinemaspacepod You can follow us on Vero @cinemaspacepodcast You can e-mail us at cinemaspacepodcast@gmail.com

Hugh Jackman is back... MAN! Deadpool 3 and Wolverine are officially coming to the MCU! He Who Remains joins Bruce Canna for a bit of X-Men nostalgia, Ryan Reynolds and Hugh Jackman's announcement, She-Hulk so far, and other upcoming projects! 90's babies... Phase 6 will be OUR Phase!!...One Drop Studios...Music by: 6DaBlakk 

Our Phase 4 celebration episode doesn’t have enough Shang-Chi. But we still get a good luck at some other peripheral Marvel characters in Heroes for Hire and The Eternals. Plus, we’ve got our usual free-range nonsense.

We still know preciously little about the upcoming fourth phase of the Marvel Cinematic Universe, save that Black Widow, Eternals, and Guardians of the Galaxy Vol. 3 are eventually coming to the big screen.  As such, the Marvel News Desk crew has put on our screenwriting and fan-casting hats in order to come up with some pitches for the […] The post Our Phase 4 Film Pitches-Marvel News Desk #94 appeared first on Marvel News Desk.

On this week’s podcast, Caleb and Adam talk about all the things we’d like to see from the returning franchises for Phase Four.  Maybe Kevin Feige won’t spill the beans about what is coming, but we’re going to give him a list of ways to continue the franchises we all know and love.  We also review the […] The post Our Phase 4 Sequel Wishlist-Marvel News Desk #78 appeared first on Marvel News Desk.

Our Phase 2 discussion begins with a surprising amount of positive things to say around Thor: The Dark World, and even more surprising criticism for Captain America: The Winter Soldier from our of roundtable members.  Plus, how does our theory of PTSD themes throughout the Iron Man series hold up as we arrive at Iron Man 3? New episodes this season every Tuesday & Thursday at 10 AM EDT! Be sure to get in touch with your questions to answer during our finale: taypodcast@gmail.com Round Table Members:@DiamondJAB@Propsofprophecy@puppupjay@sydbrnz --- Support this podcast: https://anchor.fm/s1radio/support

Our Phase 4 MCU rewatch concludes today with Doctor Strange in the Multiverse of Madness. We discuss why we feel this movie didn't fully get a fair shake and how it actually ages fairly well on a rewatch. Next week kicks off one month of Deadpool coverage including a watch through of both Deadpool 1 and Deadpool 2. You won't want to miss it!